Manus (Manus Bio) is an MIT-born industrial biotechnology company that engineers microbial cell factories and precision fermentation to produce natural ingredients - sweeteners, flavors, fragrances and pharmaceutical building blocks - that are normally extracted from plants or made from petrochemicals. Branded as 'The BioAlternatives Company,' Manus runs an R&D hub in Boston and a commercial-scale biomanufacturing plant in Augusta, Georgia, where it makes products such as monk fruit sweetener and stevia Reb M for partners including Givaudan and Tate & Lyle.
Berkeley Yeast is an Oakland-based biotechnology company that bioengineers specialized yeast strains for brewers, winemakers, and beverage makers, giving fermented drinks new flavors, greater consistency, and lower resource use without changing a brewery's existing equipment or process.
Antheia is a Menlo Park biotech using engineered yeast to brew the active ingredients behind essential medicines - replacing slow, weather-dependent poppy farming with industrial-scale fermentation. Founded out of Stanford's Smolke Lab, the company aims to end pharmaceutical shortages by turning sugar into complex molecules like thebaine in weeks instead of years.